Hamilton Lane Incorporated - Class A Common Stock (HLNE)
156.75
+6.89 (4.60%)
NASDAQ · Last Trade: Aug 23rd, 1:55 PM EDT
Detailed Quote
Previous Close
149.86
Open
150.53
Bid
62.55
Ask
204.00
Day's Range
150.09 - 157.01
52 Week Range
124.10 - 203.72
Volume
267,956
Market Cap
-
PE Ratio (TTM)
39.38
EPS (TTM)
4.0
Dividend & Yield
2.160 (1.38%)
1 Month Average Volume
361,680
Chart
About Hamilton Lane Incorporated - Class A Common Stock (HLNE)
Hamilton Lane Inc is a leading investment management firm that specializes in private markets. The company offers a range of services, including advisory, investment management, and market research, tailored to meet the needs of institutional investors and clients seeking to access the private equity and alternative investment landscape. Hamilton Lane leverages its extensive expertise and proprietary technology to provide insights and strategies that help clients navigate complex investment opportunities while aiming to optimize returns and manage risks. The firm is dedicated to enhancing transparency and efficiency in private market investing through innovative solutions and strategic guidance. Read More
A number of stocks jumped in the afternoon session after the major indices rebounded, as Fed Chair Jerome Powell delivered dovish remarks at the much-awaited Jackson Hole symposium. Powell suggested that with inflation risks moderating and unemployment remaining low, the Federal Reserve might consider a shift in its monetary policy stance, including potential interest rate cuts. This outlook eased market concerns about prolonged high interest rates and their impact on economic growth. The prospect of lower borrowing costs bolstered investor confidence, particularly in sectors that have lagged, leading to a broad rally across the market.
Hamilton Lane (HLNE) is a top growth stock with strong fundamentals and a technical setup hinting at a potential breakout, making it a compelling watch for investors.
Financial providers use their expertise in capital allocation and risk assessment to help facilitate economic growth while offering consumers and businesses essential financial services. These companies have benefited from improving market activity and economic fundamentals,
so it's no surprise the industry has posted a 4.8% gain over the past six months, nearly mirroring the S&P 500.
Hamilton Lane (HLNE) beats Q1 2026 EPS estimates by 27% but sees mixed market reaction as revenue narrowly surpasses forecasts. Shares dip pre-market amid investor caution.
Hamilton Lane (HLNE) combines strong financials with bullish technicals, offering high-growth potential in private markets with solid earnings and breakout chart patterns.
Wall Street hovered slightly higher by midday Thursday, giving up a chunk of strong overnight gains in futures markets that were triggered by a federal court ruling suspending a large portion of President Donald Trump’s tari
Hamilton Lane (NASDAQ:HLNE) excels as a quality investment with high ROIC, strong cash flow, and steady growth, making it a standout in private markets solutions.
Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has entered into a definitive agreement to acquire all the outstanding shares of Mayne Pharma Group Limited (ASX: Ticker MYX) (Mayne Pharma) at AUD$7.40/share for a total consideration of approximately USD $430 Million. The Boards of Directors of both companies have approved the transaction and Mayne Pharma’s Board of Directors has unanimously recommended that its shareholders vote in favor of the transaction. The transaction is expected to close in the second quarter of 2025.
